Veracyte Inc announced the successful completion of its Series B round, a key milestone toward the companys first product launch later this year. Veracyte seeks to develop and commercialize molecular cytology solutions to improve the early and accurate diagnosis of cancer.
Read MoreRadient Pharmaceuticals Corp (RPC) has launched a new interactive Web site for its USFDA-approved Onko-Sure in vitro diagnostic (IVD) cancer test.
Read MoreRadient Pharmaceuticals Corp announced diagnostics development and commercialization firm Provista Life Sciences LLC (PLS) has independently validated Radient Pharmaceuticals’ Onko-Sure in vitro diagnostic (IVD) cancer test.
Read More
Personalized medicine is not perfect, but it is personal. CLP looks at some new tests on the market to see how personal they are.
Read MoreThrough its US-based subsidiary AMDL Diagnostics Inc, Radient Pharmaceuticals Corp announced that it plans to expand its worldwide commercialization strategy for its Onko-Sure in vitro diagnostic cancer test to include CLIA laboratory testing services.
Read More